Authors:
Discuss the latest developments in the realm of drug safety, and expands its coverage of clinical trials considerably Provides a conceptual introduction to statistics and illustrates its important role in the new drug development process Adopts a conceptual approach, not a computational one, explaining the statistical thinking that goes into the successful planning of clinical trials
Includes supplementary material: sn.pub/extras
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (17 chapters)
-
Front Matter
-
Back Matter
About this book
Reviews
From the reviews of the second edition:
“‘New Drug Development: An Introduction to Clinical Trials, 2nd Edition’ is a solid introduction to the process of drug development, with an emphasis on clinical research, especially the statistical aspects. It is ideal for readers interested in clinical research within the broader context. The book is written in a practical and straightforward manner … .” (Norman M. Goldfarb, Journal of Clinical Research Best Practices, Vol. 9 (5), May, 2013)
Authors and Affiliations
-
Cardiac Safety Services, Quintiles, Durham, USA
J. Rick Turner
About the author
Bibliographic Information
Book Title: New Drug Development
Book Subtitle: An Introduction to Clinical Trials: Second Edition
Authors: J. Rick Turner
DOI: https://doi.org/10.1007/978-1-4419-6418-2
Publisher: Springer New York, NY
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Science+Business Media, LLC 2010
Hardcover ISBN: 978-1-4419-6417-5Published: 02 August 2010
Softcover ISBN: 978-1-4939-0091-6Published: 19 October 2014
eBook ISBN: 978-1-4419-6418-2Published: 16 July 2010
Edition Number: 2
Number of Pages: XXV, 256
Additional Information: The First Edition was published by Wiley, 2007